SLC2A1 and neoplasm: As glycolytic pathway was inhibited in mammospheres upon SrcDN induction, we investigated whether glucose consumption was altered, and found that it was significantly reduced in mammospheres expressing SrcDN (Fig 4A), which parallels a reduction in Glut-1 levels (Fig 4D), the major glucose transporter in tumor cells [37].